Literature DB >> 31807524

Comparison of the effects of photon, proton and carbon-ion radiation on the ecto-calreticulin exposure in various tumor cell lines.

Yangle Huang1,2, Yuanli Dong1,2, Jingfang Zhao2,3, Lijia Zhang2,3, Lin Kong1,2, Jiade Jay Lu1,2.   

Abstract

BACKGROUND: Accumulating evidence suggested that radiotherapy can activate anti-tumor immune responses by triggering immunogenic cell death (ICD) of tumor cells. Calreticulin is regarded as one of the most important markers of ICD. The cell surface translocation of calreticulin (ecto-CRT) serves as an "eat me" signal for phagocytosis of dying cells, which plays a pivotal role in activating anti-tumor immunity. However, there is limited knowledge describing the effects of proton and carbon-ion radiation on ecto-CRT exposure. Hence, we investigated ecto-CRT exposure in multiple human carcinoma cell lines irradiated by proton and carbon-ion in comparison to photon.
METHODS: This study examined four human cancer cell lines including A549 (lung adenocarcinoma), U251MG (glioma), Tca8113 (tongue squamous carcinoma), and CNE-2 (nasopharyngeal carcinoma). Cell lines were irradiated with photon, proton or carbon-ion at 0, 2, 4, 10 Gy (physical dose). The ecto-CRT exposure level was analyzed by flow cytometry at 12, 24, and 48 h post-irradiation. The median fluorescence intensity was calculated by FlowJo.
RESULTS: All three types of radial beam increased ecto-CRT exposure of the 4 tumor cell lines in a time-dependent manner. Ecto-CRT exposure significantly elevated 1.5-2.4 times over 48 h post-irradiation compared with controls (P<0.05). Proton and photon increased ecto-CRT exposure with dose escalation. Photon and proton at 10 Gy increased the most ecto-CRT exposure (P<0.05), while carbon-ion increased most ecto-CRT exposure at 4 Gy rather than 10 or 2 Gy. When compared with iso-physical dose at 48 h post-irradiation, proton showed a similar effectiveness with photon. While carbon-ion has significantly stronger effects on increasing ecto-CRT than proton and photon at 2 and 4 Gy, but changed oppositely at 10 Gy (P<0.05).
CONCLUSIONS: All the three types of radiation can increase the ecto-CRT exposure in a time-dependent manner. Proton and photon radiation were equally effective in inducing ecto-CRT exposure, while carbon-ion revealed a different effectiveness in comparison to photon and proton. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Calreticulin; carbon-ion; immunogenic cell death (ICD); proton

Year:  2019        PMID: 31807524      PMCID: PMC6861809          DOI: 10.21037/atm.2019.09.128

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  31 in total

Review 1.  The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant.

Authors:  Kobe Reynders; Tim Illidge; Shankar Siva; Joe Y Chang; Dirk De Ruysscher
Journal:  Cancer Treat Rev       Date:  2015-03-28       Impact factor: 12.111

Review 2.  Particle radiation therapy using proton and heavier ion beams.

Authors:  Daniela Schulz-Ertner; Hirohiko Tsujii
Journal:  J Clin Oncol       Date:  2007-03-10       Impact factor: 44.544

Review 3.  Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned.

Authors:  Joe Y Chang; Andrea Bezjak; Françoise Mornex
Journal:  J Thorac Oncol       Date:  2015-04       Impact factor: 15.609

Review 4.  Immunogenic cell death.

Authors:  Abhishek D Garg; Aleksandra M Dudek-Peric; Erminia Romano; Patrizia Agostinis
Journal:  Int J Dev Biol       Date:  2015       Impact factor: 2.203

5.  Cellular and molecular portrait of eleven human glioblastoma cell lines under photon and carbon ion irradiation.

Authors:  S Ferrandon; N Magné; P Battiston-Montagne; N-H Hau-Desbat; O Diaz; M Beuve; J Constanzo; C Chargari; D Poncet; E Chautard; D Ardail; G Alphonse; C Rodriguez-Lafrasse
Journal:  Cancer Lett       Date:  2015-02-02       Impact factor: 8.679

Review 6.  Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenic.

Authors:  Michel Obeid; Theocharis Panaretakis; Antoine Tesniere; Nick Joza; Roberta Tufi; Lionel Apetoh; François Ghiringhelli; Laurence Zitvogel; Guido Kroemer
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 12.701

Review 7.  Calreticulin, a Ca2+-binding chaperone of the endoplasmic reticulum.

Authors:  Pascal Gelebart; Michal Opas; Marek Michalak
Journal:  Int J Biochem Cell Biol       Date:  2005-02       Impact factor: 5.085

8.  Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death.

Authors:  Theocharis Panaretakis; Oliver Kepp; Ulf Brockmeier; Antoine Tesniere; Ann-Charlotte Bjorklund; Daniel C Chapman; Michael Durchschlag; Nicholas Joza; Gérard Pierron; Peter van Endert; Junying Yuan; Laurence Zitvogel; Frank Madeo; David B Williams; Guido Kroemer
Journal:  EMBO J       Date:  2009-01-22       Impact factor: 11.598

9.  Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia.

Authors:  M Wemeau; O Kepp; A Tesnière; T Panaretakis; C Flament; S De Botton; L Zitvogel; G Kroemer; N Chaput
Journal:  Cell Death Dis       Date:  2010-12-02       Impact factor: 8.469

Review 10.  Effects of Charged Particles on Human Tumor Cells.

Authors:  Kathryn D Held; Hidemasa Kawamura; Takuya Kaminuma; Athena Evalour S Paz; Yukari Yoshida; Qi Liu; Henning Willers; Akihisa Takahashi
Journal:  Front Oncol       Date:  2016-02-12       Impact factor: 6.244

View more
  16 in total

1.  The Impacts of Different Types of Radiation on the CRT and PDL1 Expression in Tumor Cells Under Normoxia and Hypoxia.

Authors:  Yangle Huang; Qingting Huang; Jingfang Zhao; Yuanli Dong; Lijia Zhang; Xumeng Fang; Pian Sun; Lin Kong; Jiade Jay Lu
Journal:  Front Oncol       Date:  2020-08-19       Impact factor: 6.244

2.  Irradiation-Induced Changes in the Immunogenicity of Lung Cancer Cell Lines: Based on Comparison of X-rays and Carbon Ions.

Authors:  Juntao Ran; Jiangtao Wang; Ziying Dai; Yandong Miao; Jian Gan; Chengpeng Zhao; Quanlin Guan
Journal:  Front Public Health       Date:  2021-04-22

Review 3.  Immunostimulatory Effects of Radiotherapy for Local and Systemic Control of Melanoma: A Review.

Authors:  Junko Takahashi; Shinsuke Nagasawa
Journal:  Int J Mol Sci       Date:  2020-12-07       Impact factor: 5.923

Review 4.  The Potentiation of Anti-Tumor Immunity by Tumor Abolition with Alpha Particles, Protons, or Carbon Ion Radiation and Its Enforcement by Combination with Immunoadjuvants or Inhibitors of Immune Suppressor Cells and Checkpoint Molecules.

Authors:  Yona Keisari; Itzhak Kelson
Journal:  Cells       Date:  2021-01-25       Impact factor: 6.600

Review 5.  Biomarkers of Radiotherapy-Induced Immunogenic Cell Death.

Authors:  Rianne D W Vaes; Lizza E L Hendriks; Marc Vooijs; Dirk De Ruysscher
Journal:  Cells       Date:  2021-04-17       Impact factor: 6.600

Review 6.  Immunogenic Cell Death Induction by Ionizing Radiation.

Authors:  Mengqin Zhu; Mengdie Yang; Jiajia Zhang; Yuzhen Yin; Xin Fan; Yu Zhang; Shanshan Qin; Han Zhang; Fei Yu
Journal:  Front Immunol       Date:  2021-08-20       Impact factor: 7.561

7.  Impact of proton therapy on antitumor immune response.

Authors:  Céline Mirjolet; Anaïs Nicol; Emeric Limagne; Carole Mura; Corentin Richard; Véronique Morgand; Marc Rousseau; Romain Boidot; François Ghiringhelli; Georges Noel; Hélène Burckel
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

Review 8.  Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment.

Authors:  Hiro Sato; Noriyuki Okonogi; Takashi Nakano
Journal:  Int J Clin Oncol       Date:  2020-04-03       Impact factor: 3.402

9.  Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory Study.

Authors:  Rianne D W Vaes; Kobe Reynders; Jenny Sprooten; Kathleen T Nevola; Kasper M A Rouschop; Marc Vooijs; Abhishek D Garg; Maarten Lambrecht; Lizza E L Hendriks; Marijana Rucevic; Dirk De Ruysscher
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639

10.  Prior nasal delivery of antagomiR-122 prevents radiation-induced brain injury.

Authors:  Haihong Zhou; Furong Sun; Mingqian Ou; Yu Zhang; Meijun Lin; Liqin Song; Yangsheng Yu; Haojie Liao; Weihao Fan; Huaijie Xing; Minhua Li; Kui Zhao; Xiaolian Wu; Yuanhong Sun; Chunmei Liang; Yujie Cai; Lili Cui
Journal:  Mol Ther       Date:  2021-06-24       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.